Simplex Trading
CERE

Simplex Trading’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Simplex Trading’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-33,600
Closed -$1.37M – 9899
2024
Q2 		$1.37M Sell
33,600
-14,500
-30% -$604K ﹤0.01% 2581
2024
Q1 		$2.03M Buy
48,100
+10,000
+26% +$420K ﹤0.01% 2393
2023
Q4 		$1.61M Sell
38,100
-45,700
-55% -$1.31M ﹤0.01% 2544
2023
Q3 		$1.83M Buy
83,800
+66,800
+393% +$1.67M ﹤0.01% 2152
2023
Q2 		$540K Sell
17,000
-23,000
-58% -$706K ﹤0.01% 3232
2023
Q1 		$975K Buy
40,000
+7,600
+23% +$223K ﹤0.01% 2608
2022
Q4 		$1.02M Sell
32,400
-33,300
-51% -$940K ﹤0.01% 2438
2022
Q3 		$1.86M Buy
65,700
+61,500
+1,464% +$1.83M ﹤0.01% 2028
2022
Q2 		$111K Buy
4,200
+1,500
+56% +$42.6K ﹤0.01% 5448
2022
Q1 		$94K Sell
2,700
-12,100
-82% -$353K ﹤0.01% 6248
2021
Q4 		$479K Sell
14,800
-61,800
-81% -$2.18M ﹤0.01% 3866
2021
Q3 		$2.06M Sell
76,600
-3,600
-4% -$101K ﹤0.01% 2099
2021
Q2 		$2.05M Buy
+80,200
New +$1.15M ﹤0.01% 2125

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Simplex Trading's CERE Position: Q3 2024 in Review

Simplex Trading sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 7,051 shares — an estimated $288K sold.

Simplex Trading first reported a position in CERE in Q2 2022 and held it in 3 quarters. The position peaked at $330K in Q2 2022. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Simplex Trading reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Simplex Trading sold 7,051 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $288K.
  • Simplex Trading first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q2 2022 and held it in 3 quarters.
  • Simplex Trading's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $330K in Q2 2022.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Simplex Trading's 13F filing for Q3 2024, filed 8 Nov 2024.